Latest Breaking News On - செவிலியர் ப்ர்யாக்டிஶநர்ஸ் - Page 7 : comparemela.com

Decision to secure supply of clomipramine hydrochloride and mirtazapine tablets 22 July 2021 What we’re doing mirtazapine and clomipramine hydrochloride tablets following the announcement that Apotex New Zealand Limited (Apotex), the current supplier, is leaving the New Zealand market. This decision means that: Mirtazapine 30 mg and 45 mg tablets A new brand of 30 mg and 45 mg mirtazapine tablets will be funded from 1 August 2021.  This will be the Noumed brand, supplied by Noumed Pharmaceuticals Limited (Noumed). The Apo-Mirtazapine brand of mirtazapine (supplied by Apotex) will continue to be funded until 1 January 2022.  From 1 January 2022, the Noumed brand of 30 mg and 45 mg mirtazapine tablets will be the only funded brand of 30 mg and 45 mg mirtazapine tablets until 30 June 2024.

New zealandNew zealandersClomipramine tevaCode of healthHealth navigatorDisability services consumer rights code ofTeva pharma new zealand limitedApotex new zealand limitedMinistry of healthNoumed pharmaceuticals limitedTeva pharmaBrand switch feePharmaceutical scheduleNurse practitionersRegistered nurse prescribersMedicines act